- 5 resultaten
laagste prijs: € 11,75, hoogste prijs: € 233,00, gemiddelde prijs: € 169,50
1
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad Chuang Lu Editor
bestellen
bij BarnesandNoble.com
€ 233,00
bestellen
Details en verzending
Gesponsorde link

Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad Chuang Lu Editor - nieuw boek

ISBN: 9780470281741

The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of e… Meer...

new in stock. Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten
dichtslaan (X)
2
Enzyme Inhibition in Drug Discovery and Development - Chuang Lu
bestellen
bij BookDepository.com
€ 194,60
verzending: € 0,001
bestellen
Details aangeboden
Gesponsorde link

Chuang Lu:

Enzyme Inhibition in Drug Discovery and Development - gebonden uitgave, pocketboek

ISBN: 9780470281741

Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Meer...

Verzendingskosten:Versandkostenfrei. (EUR 0.00)
dichtslaan (X)
3
Enzyme Inhibition in Drug Discovery and Development - Chuang Lu
bestellen
bij BookDepository.com
€ 195,00
verzending: € 0,001
bestellen
Details aangeboden
Gesponsorde link
Chuang Lu:
Enzyme Inhibition in Drug Discovery and Development - gebonden uitgave, pocketboek

ISBN: 9780470281741

Hardback, [PU: John Wiley & Sons Inc], This book covers the science and approaches of enzyme inhibition applied in drug discovery and drug development, including both pharmacology and pha… Meer...

Verzendingskosten:Versandkostenfrei. (EUR 0.00)
dichtslaan (X)
4
bestellen
bij Biblio.co.uk
$ 14,01
(ongeveer € 11,75)
verzending: € 10,901
bestellen
Details aangeboden
Gesponsorde link
Editor-Chuang Lu; Editor-Albert P. Li:
Enzyme Inhibition in Drug Discovery and Development: The Good and the Bad - gebonden uitgave, pocketboek

2010, ISBN: 9780470281741

Wiley, 2010-01-07. Hardcover. Good., Wiley, 2010-01-07, 2.5

Verzendingskosten: EUR 10.90 Ergodebooks
dichtslaan (X)
5
bestellen
bij lehmanns.de
€ 213,14
verzending: € 0,001
bestellen
Details aangeboden
Gesponsorde link
Chuang Lu; Albert P. Li:
Enzyme Inhibition in Drug Discovery and Development - gebonden uitgave, pocketboek

2009, ISBN: 9780470281741

The Good and the Bad, Hardcover, Buch, [PU: John Wiley & Sons Inc]

Verzendingskosten:Versand in 10-15 Tagen, , Versandkostenfrei innerhalb der BRD. (EUR 0.00)
dichtslaan (X)
1Aangezien sommige platformen geen verzendingsvoorwaarden meedelen en deze kunnen afhangen van het land van levering, de aankoopprijs, het gewicht en de grootte van het artikel, een eventueel lidmaatschap van het platform, een rechtstreekse levering door het platform of via een derde aanbieder (Marktplaats), enz., is het mogelijk dat de door euro-boek.nl meegedeelde verzendingskosten niet overeenstemmen met deze van het aanbiedende platform.

Bibliografische gegevens van het best passende boek

Bijzonderheden over het boek
Enzyme Inhibition in Drug Discovery and Development
auteur:
Titel:
ISBN:

047028174X


The science and applied approaches of enzyme inhibition in drug discovery and development Offering a unique approach that includes both the pharmacologic and pharmaco-kinetic aspects of enzyme inhibition, Enzyme Inhibition in Drug Discovery and Development examines the scientific concepts and experimental approaches related to enzyme inhibition as applied in drug discovery and drug development. With chapters written by over fifty leading experts in their fields, Enzyme Inhibition in Drug Discovery and Development fosters a cross-fertilization of pharmacology, drug metabolism, pharmacokinetics, and toxicology by understanding the "good" inhibitions--desirable pharmacological effects--and "bad" inhibitions--drug-drug interactions and toxicity. The book discusses: * The drug discovery process, including drug discovery strategy, medicinal chemistry, analytical chemistry, drug metabolism, pharmacokinetics, and safety biomarker assessment * The manipulations of drug metabolizing enzymes and transporters as well as the negative consequences, such as drug-drug interactions * The inhibition of several major drug target pathways, such as the GPCR pathway, the NFkB pathway, and the ion channel pathway Through this focused, single-source reference on the fundamentals of drug discovery and development, researchers in drug metabolism and pharmacokinetics (DMPK) will learn and appreciate target biology in drug discovery; discovery biologists and medicinal chemists will also broaden their understanding of DMPK.

Gedetalleerde informatie over het boek. - Enzyme Inhibition in Drug Discovery and Development


EAN (ISBN-13): 9780470281741
ISBN (ISBN-10): 047028174X
Gebonden uitgave
Verschijningsjaar: 2010
Uitgever: John Wiley & Sons Inc
854 Bladzijden
Gewicht: 1,270 kg
Taal: eng/Englisch

Boek bevindt zich in het datenbestand sinds 2010-08-19T12:13:25+02:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2022-02-01T11:38:54+01:00 (Amsterdam)
ISBN/EAN: 047028174X

ISBN - alternatieve schrijfwijzen:
0-470-28174-X, 978-0-470-28174-1
alternatieve schrijfwijzen en verwante zoekwoorden:
Auteur van het boek: chuang, chuan
Titel van het boek: enzyme, development inhibition, the enzymes

Gegevens van de uitgever

Auteur: Chuang Lu; Albert P. Li
Titel: Enzyme Inhibition in Drug Discovery and Development - The Good and the Bad
Uitgeverij: John Wiley & Sons
868 Bladzijden
Verschijningsjaar: 2010-01-26
Gewicht: 1,274 kg
Taal: Engels
195,00 € (DE)
Not available (reason unspecified)
165mm x 240mm x 43mm

BB; GB; Hardcover, Softcover / Chemie; Chemie; Pharmakologie u. Pharmazeutische Medizin; Drug Discovery & Development; Enzymes & Receptors; Medical Science; Enzyme u. Rezeptoren; Wirkstoffforschung u. -entwicklung; Enzyme; Chemistry; Medizin; Wirkstoffforschung; Pharmacology & Pharmaceutical Medicine; Chemie; Pharmakologie

PREFACE. CONTRIBUTORS. PART I. DRUG DISCOVERY APPROACHES AND TECHNOLOGIES. 1. The Drug Discovery Process (Gerald T. Miwa). 2. Medicinal Chemistry of the Optimization of Enzyme Inhibitors (Geraldine Harriman, Amy Elder, and Indranath Ghosh). 3. Bioanalytical Technologies in Drug Discovery (Jing-Tao Wu). 4. Safety Biomarkers in Drug Development: Emerging Trends and Implications (Eric R. Fedyk). 5. The Role of Drug Metabolism in Drug Discovery (Tonika Bohnert and Liang-Shang Gan). 6. Applied Pharmacokinetics in Drug Discovery and Development (Hua Yang, Xingrong Liu, Anjaneya Chimalakonda, Zheng Lu, Cuiping Chen, Frank Lee, and Wen Chyi Shyu). PART II. INHIBITION OF THE DRUG METABOLIZING ENZYMES--THE UNDESIRABLE INHIBITION. 7. Enzyme Inhibition and Inactivation: Cytochrome P450 Enzymes (R. Scott Obach). 8. Cytochrome P450 Induction (Edward L. LeCluyse, Michael W. Sinz, Nicola Hewitt, Stephen S. Ferguson, and Jasminder Sahi). 9. Inhibition of Drug-Metabolizing Enzymes in Gastrointestinal Tract and Its Influence on the Drug-Drug Interaction Prediction (Aleksandra Galetin and J. Brian Houston). 10. Enzyme Inhibition in Various In Vitro Systems (Ping Zhou). 11. Cytochrome P450 Degradation and Its Clinical Relevance (Mingxiang Liao, Ping Kang, Bernard P. Murray, and Maria Almira Correia). 12. Complexities of Working with UDP-Glucuronosyltransferases (UGTs): Focus on Enzyme Inhibition (Michael B. Fisher). 13. Evaluation of Inhibitors of Drug Metabolism in Human Hepatocytes (Albert P. Li and Chuang Lu). 14. Grapefruit Juice and Its Constituents as New Esterase Inhibitors (Suresh K. Balani). 15. Transporter-Xenobiotic Interactions: An Important Aspect of Drug Development Studies (Gang Luo, Richard Ridgewell, and Thomas Guenthner). 16. Polymorphisms of Drug Transporters and Their Clinical Implications (Cindy Q. Xia and Johnny J. Yang). 17. Clinical Drug Interactions Due to Metabolic Inhibition: Prediction, Assessment, and Interpretation (Lisa L. von Moltke and David J. Greenblatt). 18. Predicting Interindividual Variability of Metabolic Drug-Drug Interactions: Identifying the Causes and Accounting for Them Using Systems Approach (Amin Rostami-Hodjegan). PART III. INHIBITION OF THE DRUG TARGET ENZYMES--THE DESIRABLE INHIBITION. 19. NF-ºB: Mechanism, Tumor Biology, and Inhibitors (Lenny Dang). 20. G-Protein-Coupled Receptors as Drug Targets (Wenyan Miao and Lijun Wu). 21. Pharmacological Modulation of Ion Channels for the Treatment of Chronic Pain (Yi Liu and Ning Qin). 22. Targeting the mTOR Pathway for Tumor Therapeutics (Wei Chen). 23. HIV-1 Protease Inhibitors as Antiretroviral Agents (Sergei V. Gulnik, Elena Afonina, and Michael Eissenstat). INDEX.

Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:

Laatste soortgelijke boek:
9780470538944 Enzyme Inhibition in Drug Discovery and Development (Chuang Lu; Albert P. Li)

< naar Archief...